Troxerutin subdues hepatic tumorigenesis via disrupting the MDM2–p53 interaction
- 27 September 2018
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 9 (10) , 5336-5349
Abstract
Hepatocellular carcinoma (HCC) is the leading cause of cancer death worldwide that lacks proper medical prognosis and treatment. In the present study, the anti-tumoral potential of troxerutin (TX), an ethnomedicine, was examined in relation to its effects on the promoter 2-acetylaminofluorene (2-AAF) in N-nitrosodiethylamine (NDEA) initiated HCC, as compared to its effects on HCC induced by NDEA alone. Liver samples from each experimental group were collected and evaluated for histological, biochemical and cellular characterization. The protein expressions of apoptotic and cell proliferation markers were determined via immunohistochemistry and western blotting. Molecular docking was also performed to delineate the inhibitory mechanism of TX on HCC. The results show that only higher doses of TX showed a significant reduction in the incidence of hepatic nodule formation, and they also counteracted NDEA plus 2-AAF induced alterations in the enzymic status. The frequencies of glutathione-S-transferase and proliferating cell nuclear antigen, markers of S phase progression, were markedly reduced during TX treatment. TX also modulated the imbalance in the MDM2–p53 interaction. The molecular docking results confirmed the interaction of TX with the upstream kinases that regulate apoptosis. This study provides evidence that a copious dose of TX is required to counteract the differential mitoinhibitory effect of 2-AAF in NDEA initiated hepatomas, and TX exhibits an anti-tumoral effect via suppressing oxidative stress, regulating liver function enzymes, inhibiting inflammatory responses and modulating MDM2–p53 interactions, thus inducing apoptosis, and thereby suggesting that TX may provide promising therapeutic effects for the chemoprevention of HCC.Keywords
Funding Information
- Department of Science and Technology, Ministry of Science and Technology, India (IF130537)
This publication has 51 references indexed in Scilit:
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing plateletsNature Medicine, 2013
- DEN+2-AAF-induced multistep hepatotumorigenesis in Wistar rats: supportive evidence and insightsProtoplasma, 2012
- Protective Effects of Garlic Oil on Hepatocarcinoma Induced by N-Nitrosodiethylamine in RatsInternational Journal of Biological Sciences, 2012
- PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegenerationCell Communication and Signaling, 2010
- Hepatic Stellate Cells in Inflammation‐Fibrosis‐Carcinoma AxisThe Anatomical Record, 2010
- Troxerutin Protects the Mouse Liver against Oxidative Stress-Mediated Injury Induced byd-GalactoseJournal of Agricultural and Food Chemistry, 2009
- Isoquinoline-1,3,4-trione Derivatives Inactivate Caspase-3 by Generation of Reactive Oxygen SpeciesJournal of Biological Chemistry, 2008
- Polymorphic metabolism of the carcinogen 2-acetylaminofluorene in human liver microsomesCarcinogenesis, 1985
- Dt diaphorase I. Purification from the soluble fraction of rat-liver cytoplasm, and propertiesBiochimica et Biophysica Acta, 1962
- Solubilization and purification of glucuronyl transferase from rabbit liver microsomesBiochemical and Biophysical Research Communications, 1961